Literature DB >> 2113001

Nitrate tolerance. A problem during continuous nitrate administration.

J O Parker1.   

Abstract

The organic nitrates are effective agents in the management of patients with angina pectoris. They are the agents of choice in the treatment of acute episodes of angina pectoris and are useful in angina prophylaxis. While the organic nitrates are extremely effective in angina prophylaxis during acute therapy, there is increasing evidence that with many dosing regimens for oral and transdermal therapy, substantial attenuation of the antianginal effects develops. Thus, during acute therapy the organic nitrates improve exercise tolerance for many hours, but during sustained therapy designed to provide antianginal efficacy throughout the 24-h period there is significant attenuation of the beneficial effects. It has been documented that treatment regimens designed to provide a period of nitrate washout prevent or reverse nitrate tolerance, and such changes in dosing regimens have been shown to provide continued antianginal protection. It is clear that the objective of providing 24-h antianginal protection with the organic nitrates cannot be achieved. With appropriate dosing schedules, however, it is possible to improve exercise tolerance throughout the major portion of the 24-h dosing period.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2113001     DOI: 10.1007/bf01417561

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  23 in total

1.  Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance.

Authors:  U Thadani; S F Hamilton; E Olson; J Anderson; W Voyles; R Prasad; S M Teague
Journal:  Ann Intern Med       Date:  1986-10       Impact factor: 25.391

2.  Prevention of tolerance to nitroglycerin patches by overnight removal.

Authors:  J C Cowan; J P Bourke; D S Reid; D G Julian
Journal:  Am J Cardiol       Date:  1987-08-01       Impact factor: 2.778

3.  Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure.

Authors:  U Elkayam; D Kulick; N McIntosh; A Roth; W Hsueh; S H Rahimtoola
Journal:  Circulation       Date:  1987-09       Impact factor: 29.690

4.  Transdermal isosorbide dinitrate in angina pectoris: effect of acute and sustained therapy.

Authors:  J O Parker; K A VanKoughnett; H L Fung
Journal:  Am J Cardiol       Date:  1984-07-01       Impact factor: 2.778

5.  A preliminary double-blind study of intravenous nitroglycerin in acute myocardial infarction.

Authors:  Y Lis; D Bennett; G Lambert; D Robson
Journal:  Intensive Care Med       Date:  1984       Impact factor: 17.440

6.  Nitrate tolerance: the lack of effect of N-acetylcysteine.

Authors:  J O Parker; B Farrell; K A Lahey; B F Rose
Journal:  Circulation       Date:  1987-09       Impact factor: 29.690

7.  Prevention and reversal of tolerance to nitroglycerine with N-acetylcysteine.

Authors:  J Torresi; J D Horowitz; G J Dusting
Journal:  J Cardiovasc Pharmacol       Date:  1985 Jul-Aug       Impact factor: 3.105

8.  Dose requirements and hemodynamic effects of transdermal nitroglycerin compared with placebo in patients with congestive heart failure.

Authors:  R A Jordan; L Seith; D A Henry; M M Wilen; J A Franciosa
Journal:  Circulation       Date:  1985-05       Impact factor: 29.690

9.  Nitroglycerin ointment effective for seven hours in severe angina pectoris.

Authors:  R Kala; P Hirvonen; A Gordin; S Sundberg; J Auvinen; P I Halonen
Journal:  Acta Med Scand       Date:  1983

10.  Desensitization to nitroglycerin in vascular smooth muscle from rat and human.

Authors:  S A Waldman; R M Rapoport; R Ginsburg; F Murad
Journal:  Biochem Pharmacol       Date:  1986-10-15       Impact factor: 5.858

View more
  2 in total

Review 1.  Nitrate tolerance in angina therapy. How to avoid it.

Authors:  J D Rutherford
Journal:  Drugs       Date:  1995-02       Impact factor: 9.546

2.  Inhaled nitric oxide reduces secondary brain damage after traumatic brain injury in mice.

Authors:  Nicole A Terpolilli; Seong-Woong Kim; Serge C Thal; Wolfgang M Kuebler; Nikolaus Plesnila
Journal:  J Cereb Blood Flow Metab       Date:  2012-11-28       Impact factor: 6.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.